Literature DB >> 15944034

Galanin and galanin receptors in human cancers.

Alexandra Berger1, Radmila Santic, Cornelia Hauser-Kronberger, Freimut H Schilling, Per Kogner, Manfred Ratschek, Agnes Gamper, Neil Jones, Wolfgang Sperl, Barbara Kofler.   

Abstract

The increasing interest in peptides and peptide receptors in cancer is based on the possibility of receptor targeting, because peptide receptors are often expressed in different human tumors. The neuropeptide galanin has also been suggested to be involved in the development of neuroendocrine tumors based on the development of estrogen-induced tumors in estrogen-sensitive rats. This study summarizes our current knowledge on the expression of galanin peptide and galanin receptors in different human neuroendocrine tumors. The expression of both, peptide and corresponding receptor, seems to be a common feature of human gliomas, pheochromocytomas, pituitary and neuroblastic tumors. The co-expression of galanin and its receptors supports a role for galanin in tumor cell pathology via autocrine/paracrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944034     DOI: 10.1016/j.npep.2004.12.016

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  18 in total

1.  Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).

Authors:  R Tofighi; B Joseph; S Xia; Z-Q D Xu; B Hamberger; T Hökfelt; S Ceccatelli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

2.  Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene.

Authors:  Radmila Santic; Katrin Fenninger; Kerstin Graf; Rainer Schneider; Cornelia Hauser-Kronberger; Freimut H Schilling; Per Kogner; Manfred Ratschek; Neil Jones; Wolfgang Sperl; Barbara Kofler
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Authors:  Cameron S Metcalf; Misty D Smith; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Grzegorz Bulaj
Journal:  Neurochem Res       Date:  2017-04-06       Impact factor: 3.996

4.  Diagnostic value of serum levels of galanin and obestatin in patients with gastric cancer.

Authors:  Furkan Ali Uygur; Esra Dişçi; Rıfat Peksöz; Nurinnisa Öztürk; Mehmet İlhan Yildirgan; Yavuz Albayrak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

5.  Expression of alarin in ependymoma and choroid plexus tumors.

Authors:  Nicole Eberhard; Serge Weis; Herbert Reitsamer; Barbara Kofler
Journal:  J Neurooncol       Date:  2013-06-13       Impact factor: 4.130

6.  Alarin is a vasoactive peptide.

Authors:  Radmila Santic; Sabine M Schmidhuber; Roland Lang; Isabella Rauch; Elena Voglas; Nicole Eberhard; Johann W Bauer; Susan D Brain; Barbara Kofler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 7.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

8.  Marek's disease virus infection induces widespread differential chromatin marks in inbred chicken lines.

Authors:  Apratim Mitra; Juan Luo; Huanming Zhang; Kairong Cui; Keji Zhao; Jiuzhou Song
Journal:  BMC Genomics       Date:  2012-10-16       Impact factor: 3.969

9.  miR-1289 and "Zipcode"-like Sequence Enrich mRNAs in Microvesicles.

Authors:  Mehmet Fatih Bolukbasi; Arda Mizrak; Gokhan Baris Ozdener; Sibylle Madlener; Thomas Ströbel; Erdogan Pekcan Erkan; Jian-Bing Fan; Xandra O Breakefield; Okay Saydam
Journal:  Mol Ther Nucleic Acids       Date:  2012-02-07       Impact factor: 10.183

10.  Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.

Authors:  Takayuki Uehara; Takeharu Kanazawa; Hiroaki Mizukami; Ryosuke Uchibori; Tomonori Tsukahara; Masashi Urabe; Akihiro Kume; Kiyoshi Misawa; Thomas E Carey; Mikio Suzuki; Keiichi Ichimura; Keiya Ozawa
Journal:  Cancer Sci       Date:  2013-12-01       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.